Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY (DEFICIT)

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)
Total
Series B Warrant
Common Stock Warrants
Prefunded Warrants
Common Stock
Common Stock
Series B Warrant
Common Stock
Common Stock Options
Common Stock
Common Stock Warrants
Common Stock
Prefunded Warrants
Additional Paid-In Capital
Additional Paid-In Capital
Series B Warrant
Additional Paid-In Capital
Common Stock Options
Additional Paid-In Capital
Common Stock Warrants
Accumulated Deficit
Accumulated Deficit
Common Stock Options
Beginning balance (in shares) at Dec. 31, 2019         182,895,247                    
Beginning balance at Dec. 31, 2019 $ 548,058       $ 182,895         $ 32,538,445       $ (32,173,282)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Stock-based compensation expense 64,142                 64,142          
Warrant exercise (in shares)           312,500                  
Warrant exercise   $ 26,563       $ 313         $ 26,250        
Net loss (2,341,660)                         (2,341,660)  
Ending balance (in shares) at Mar. 31, 2020         183,207,747                    
Ending balance at Mar. 31, 2020 (1,702,897)       $ 183,208         32,628,837       (34,514,942)  
Beginning balance (in shares) at Dec. 31, 2019         182,895,247                    
Beginning balance at Dec. 31, 2019 548,058       $ 182,895         32,538,445       (32,173,282)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net loss (3,761,896)                            
Ending balance (in shares) at Jun. 30, 2020         183,207,747                    
Ending balance at Jun. 30, 2020 (3,094,424)       $ 183,208         32,657,546       (35,935,178)  
Beginning balance (in shares) at Mar. 31, 2020         183,207,747                    
Beginning balance at Mar. 31, 2020 (1,702,897)       $ 183,208         32,628,837       (34,514,942)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Stock-based compensation expense 28,709                 28,709          
Net loss (1,420,236)                         (1,420,236)  
Ending balance (in shares) at Jun. 30, 2020         183,207,747                    
Ending balance at Jun. 30, 2020 (3,094,424)       $ 183,208         32,657,546       (35,935,178)  
Beginning balance (in shares) at Dec. 31, 2020         288,074,415                    
Beginning balance at Dec. 31, 2020 450,786       $ 288,074         38,896,693       (38,733,981)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Stock-based compensation expense (in shares)         600,000                    
Stock-based compensation expense 146,580       $ 600         145,980          
Warrant exercise (in shares)               67,166,667 11,800,000            
Warrant exercise     $ 4,030,000 $ 11,800       $ 67,167 $ 11,800       $ 3,962,833    
Net loss (2,160,517)                         (2,160,517)  
Ending balance (in shares) at Mar. 31, 2021         367,641,082                    
Ending balance at Mar. 31, 2021 2,478,649       $ 367,641         43,005,506       (40,894,498)  
Beginning balance (in shares) at Dec. 31, 2020         288,074,415                    
Beginning balance at Dec. 31, 2020 450,786       $ 288,074         38,896,693       (38,733,981)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Warrant exercise (in shares)       11,800,000                      
Net loss (4,184,544)                            
Ending balance (in shares) at Jun. 30, 2021         396,080,666                    
Ending balance at Jun. 30, 2021 2,271,104       $ 396,081         44,793,548       (42,918,525)  
Beginning balance (in shares) at Mar. 31, 2021         367,641,082                    
Beginning balance at Mar. 31, 2021 2,478,649       $ 367,641         43,005,506       (40,894,498)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Stock-based compensation expense 111,699                 111,699          
Warrant exercise (in shares)             106,250 28,333,334              
Warrant exercise     $ 1,700,000       $ 107 $ 28,333       $ 4,676 $ 1,671,667   $ 4,783
Net loss (2,024,027)                         (2,024,027)  
Ending balance (in shares) at Jun. 30, 2021         396,080,666                    
Ending balance at Jun. 30, 2021 $ 2,271,104       $ 396,081         $ 44,793,548       $ (42,918,525)